In Response to Cost-effectiveness Analysis of Inferior Turbinate Reduction and Immunotherapy in Allergic Rhinitis
Laryngoscope
.
2024 Apr;134(4):E14-E15.
doi: 10.1002/lary.31247.
Epub 2023 Dec 28.
Authors
Michael Yong
1
,
Kaishan Aravinthan
2
,
Keshinisuthan Kirubalingam
3
,
Andrew Thamboo
2
,
Peter H Hwang
4
,
Kari Nadeau
5
,
Evan Walgama
6
Affiliations
1
Pacific Neuroscience Institute, Santa Monica, California, U.S.A.
2
Division of Otolaryngology-Head and Neck Surgery, University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada.
3
Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada.
4
Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, U.S.A.
5
Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, U.S.A.
6
Department of Otolaryngology-Head and Neck Surgery, Cedars-Sinai, Los Angeles, California, U.S.A.
PMID:
38153190
DOI:
10.1002/lary.31247
No abstract available
Publication types
Letter
MeSH terms
Cost-Effectiveness Analysis*
Humans
Immunotherapy
Nasal Mucosa
Rhinitis, Allergic* / therapy
Turbinates / surgery